ZIMMER BIOMET HOLDINGS, INC. Repayments of Unsecured Debt
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Repayments of Unsecured Debt of $33.90 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfUnsecuredDebt · last filed 2023-08-01
- ZIMMER BIOMET HOLDINGS, INC. repayments of unsecured debt for the quarter ending 2023-06-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. repayments of unsecured debt for the quarter ending 2023-03-31 was $33.90M.
- ZIMMER BIOMET HOLDINGS, INC. repayments of unsecured debt for the quarter ending 2022-12-31 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. repayments of unsecured debt for the quarter ending 2019-12-31 was $210.00M, a 77.30% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. repayments of unsecured debt for fiscal 2022 was $242.90M.
- ZIMMER BIOMET HOLDINGS, INC. repayments of unsecured debt for fiscal 2018 was $1.43B, a 51.60% increase from fiscal 2017.
- ZIMMER BIOMET HOLDINGS, INC. repayments of unsecured debt for fiscal 2017 was $940.00M.
| Period end | Repayments of Unsecured Debt 3 month | Repayments of Unsecured Debt 6 month | Repayments of Unsecured Debt 9 month | Repayments of Unsecured Debt 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $33.90M 10-Q · filed 2023-08-01 | $33.90M derived: sum of 3 quarters · filed 2023-08-01 | |
| 2023-03-31 | $33.90M 10-Q · filed 2023-05-02 | $33.90M derived: sum of 2 quarters · filed 2023-05-02 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $242.90M 10-K · filed 2023-02-24 | ||
| 2022-09-30 | $242.90M 10-Q · filed 2022-11-02 | |||
| 2019-12-31 | $210.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-06-22 | $535.00M derived: sum of 2 quarters · filed 2022-06-22 | $650.00M derived: sum of 3 quarters · filed 2022-06-22 | $960.00M 8-K · filed 2022-06-22 |
| 2019-09-30 | $325.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $440.00M derived: sum of 2 quarters · filed 2020-11-06 | $750.00M 10-Q · filed 2020-11-06 | $1.68B derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $115.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $425.00M 10-Q · filed 2020-08-05 | $1.35B derived: sum of 3 quarters · filed 2021-02-22 | |
| 2019-03-31 | $310.00M 10-Q · filed 2020-05-11 | $1.24B derived: sum of 2 quarters · filed 2021-02-22 | ||
| 2018-12-31 | $925.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $1.43B 10-K · filed 2021-02-22 | ||
| 2018-09-30 | $500.00M 10-Q · filed 2019-11-05 | |||
| 2017-12-31 | $940.00M 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |